Profund Advisors LLC Allogene Therapeutics, Inc. Transaction History

Profund Advisors LLC

$2.67 Billion
Q4 2024

A detailed history of Profund Advisors LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 70,325 shares of ALLO stock, worth $139,946. This represents 0.01% of its overall portfolio holdings.

Number of Shares

70,325

Previous 62,634 12.28%

Holding current value

$139,946

Previous $175,000 14.86%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$1.84 - $3.22 $14,151 - $24,765	7,691 Added 12.28%	70,325 $149,000
Q3 2024 Nov 13, 2024	SELL	$2.08 - $3.5 $28,134 - $47,341	-13,526 Reduced 17.76%	62,634 $175,000
Q2 2024 Aug 13, 2024	SELL	$2.23 - $4.38 $100,124 - $196,657	-44,899 Reduced 37.09%	76,160 $177,000
Q1 2024 May 08, 2024	BUY	$2.92 - $5.63 $353,492 - $681,562	121,059 New	121,059 $541,000
Q3 2023 Nov 13, 2023	SELL	$3.17 - $5.96 $20,899 - $39,294	-6,593 Reduced 4.8%	130,639 $414,000
Q2 2023 Aug 10, 2023	BUY	$4.53 - $6.74 $57,173 - $85,065	12,621 Added 10.13%	137,232 $682,000
Q1 2023 May 11, 2023	BUY	$4.92 - $8.21 $613,086 - $1.02 Million	124,611 New	124,611 $615,000
Q2 2022 Aug 01, 2022	SELL	$6.78 - $12.28 $6,874 - $12,451	-1,014 Reduced 9.02%	10,229 $117,000
Q1 2022 May 10, 2022	SELL	$7.65 - $15.29 $9,554 - $19,097	-1,249 Reduced 10.0%	11,243 $102,000
Q4 2021 Feb 08, 2022	SELL	$13.13 - $24.52 $19,537 - $36,485	-1,488 Reduced 10.64%	12,492 $186,000
Q3 2021 Nov 12, 2021	BUY	$21.01 - $27.64 $13,257 - $17,440	631 Added 4.73%	13,980 $359,000
Q2 2021 Aug 12, 2021	BUY	$23.49 - $35.8 $1,291 - $1,968	55 Added 0.41%	13,349 $348,000
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $33,320 - $50,413	-1,292 Reduced 8.86%	13,294 $469,000
Q4 2020 Feb 09, 2021	BUY	$25.24 - $43.45 $36,698 - $63,176	1,454 Added 11.07%	14,586 $368,000
Q3 2020 Nov 13, 2020	SELL	$32.38 - $44.96 $63,011 - $87,492	-1,946 Reduced 12.91%	13,132 $495,000
Q2 2020 Aug 03, 2020	BUY	$18.39 - $54.04 $89,504 - $263,012	4,867 Added 47.66%	15,078 $646,000
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $74,501 - $115,514	-4,089 Reduced 28.59%	10,211 $199,000
Q4 2019 Feb 18, 2020	BUY	$24.82 - $31.4 $42,491 - $53,756	1,712 Added 13.6%	14,300 $372,000
Q3 2019 Nov 12, 2019	BUY	$26.11 - $32.99 $328,672 - $415,278	12,588 New	12,588 $343,000

Others Institutions Holding ALLO

# of Institutions

176

Shares Held

139M

Call Options Held

75.8K

Put Options Held

52.8K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $286M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account

Profund Advisors LLC Allogene Therapeutics, Inc. Transaction History